L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
NCT03982160
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Chronic Kidney Disease
Interventions
DRUG:
L-Arginine
OTHER:
Placebo
Sponsor
The University of Texas at Arlington